INTERNATIONAL PATENT: CELEST THERAPEUTICS (SHANGHAI) CO., LTD, CELEST THERAPEUTICS FILES APPLICATION FOR "ANTI-CLAUDIN18.2 NANOBODY, CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF"

GENEVA, Feb. 8 -- CELEST THERAPEUTICS (SHANGHAI) CO., LTD (Room 368, Unit 302, No. 211 Fute North Road, China (Shanghai) Pilot Free Trade ZonePudong New Area, Shanghai 200120), CELEST THERAPEUTICS (Grand Pavilion Commercial Centre, Suite 24, 802 West Bay Road, P.O. Box 10281, Grand Cayman KY1-1003) filed a patent application (PCT/CN2025/112225) for "ANTI-CLAUDIN18.2 NANOBODY, CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF" on Aug 01, 2025. With publication no. WO/2026/026965, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FE...